Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23176621)

1.

Why do targeted agents not work in the adjuvant setting in colon cancer?

Oyan B.

Expert Rev Anticancer Ther. 2012 Oct;12(10):1337-45. doi: 10.1586/era.12.111. Review.

PMID:
23176621
2.

Targeted agents for adjuvant therapy of colon cancer.

Saif MW.

Clin Colorectal Cancer. 2006 May;6(1):46-51.

PMID:
16796791
3.

[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].

Medinger M, Steinbild S, Mross K.

Praxis (Bern 1994). 2004 Sep 29;93(40):1633-44. Review. German.

PMID:
15495753
4.

Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer.

Bonetti A, Giuliani J, Muggia F.

Anticancer Res. 2014 Jan;34(1):423-34. Review.

PMID:
24403498
5.

Adjuvant chemotherapy for stages II, III and IV of colon cancer.

Grávalos C, García-Escobar I, García-Alfonso P, Cassinello J, Malón D, Carrato A.

Clin Transl Oncol. 2009 Aug;11(8):526-33. Review.

PMID:
19661027
6.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
7.

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.

Allegra CJ, Yothers G, O'Connell MJ, Sharif S, Colangelo LH, Lopa SH, Petrelli NJ, Goldberg RM, Atkins JN, Seay TE, Fehrenbacher L, O'Reilly S, Chu L, Azar CA, Wolmark N.

J Clin Oncol. 2009 Jul 10;27(20):3385-90. doi: 10.1200/JCO.2009.21.9220. Epub 2009 May 4.

8.

From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer.

de Gramont A, de Gramont A, Chibaudel B, Bachet JB, Larsen AK, Tournigand C, Louvet C, André T; GERCOR (French Oncology Research Group).

Semin Oncol. 2011 Aug;38(4):521-32. doi: 10.1053/j.seminoncol.2011.05.006. Review.

PMID:
21810511
9.

[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?].

André T, Larsen AK, de Gramont A.

Bull Cancer. 2012 Jun;99(6):607-8. French. No abstract available.

PMID:
22900267
10.

Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.

Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS.

J Clin Oncol. 2011 Aug 20;29(24):3255-62. doi: 10.1200/JCO.2011.35.0058. Epub 2011 Jul 18. Erratum in: J Clin Oncol. 2012 Jan 20;30(3):343.

11.

Lessons from the adjuvant bevacizumab trial on colon cancer: what next?

Van Cutsem E, Lambrechts D, Prenen H, Jain RK, Carmeliet P.

J Clin Oncol. 2011 Jan 1;29(1):1-4. doi: 10.1200/JCO.2010.32.2701. Epub 2010 Nov 29. No abstract available.

12.

Integration of novel agents in the treatment of colorectal cancer.

Iqbal S, Lenz HJ.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. Review.

PMID:
15309512
13.

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

Tappenden P, Jones R, Paisley S, Carroll C.

Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.

14.

An overview of approaches to adjuvant therapy for colorectal cancer in the United States.

Hobday TJ.

Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S11-8. Review.

PMID:
15871761
15.

An overview of adjuvant systemic chemotherapy for colon cancer.

Andre T, de Gramont A; Study Group of Clinical Research in Radiotherapies Oncology, Oncology Multidiciplinary Research Group.

Clin Colorectal Cancer. 2004 Jun;4 Suppl 1:S22-8. Review.

PMID:
15212702
16.

Adjuvant treatment of colon cancer: what is next?

Van Loon K, Venook AP.

Curr Opin Oncol. 2011 Jul;23(4):403-9. doi: 10.1097/CCO.0b013e3283479c83. Review.

PMID:
21537178
17.

Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.

Goffin JR, Talavera JR.

J Clin Oncol. 2006 Jan 20;24(3):528-9; author reply 529-30. No abstract available.

18.

Targeted agents for adjuvant therapy of colon cancer.

de Gramont A, Tournigand C, André T, Larsen AK, Louvet C.

Semin Oncol. 2006 Dec;33(6 Suppl 11):S42-5. Review.

PMID:
17178286
19.

Adjuvant therapy in colon cancer--what, when and how?

Chau I, Cunningham D.

Ann Oncol. 2006 Sep;17(9):1347-59. Epub 2006 Mar 8. Review.

20.

Effects of 5-fluorouracil adjuvant treatment of colon cancer.

Kelder W, Hospers GA, Plukker JT.

Expert Rev Anticancer Ther. 2006 May;6(5):785-94. Review.

PMID:
16759168
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk